Pyrazole derivatives useful as 5-lipoxygenase activating protein (FLAP) inhibitors
AssigneeAstraZeneca AB
InventorsJohan Olof Broddefalk, Hans Fredrik Emtenâs, Kenneth Lars Granberg, Malin Anita Lemurell, Daniel Tor Pettersen, Alleyn Thomas Plowright, Lars Johan Andreas Ulander
Life of this patent
Estimating the term…
Abstract
The present application relates to novel compounds of formula (I) to their utility in treating and/or preventing clinical conditions including cardiovascular diseases (CVD), to methods for their therapeutic use, to pharmaceutical compositions containing them and to processes for preparing such compounds.
Claims5
A method of treating or preventing a respiratory inflammatory disease, comprising administering to a patient a compound which is (1R,2R)-2-[4-(3-Methyl-1H-pyrazol-5-yl)benzoyl]-N-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-α] pyrazin-3-yl)cyclohexanecarboxamide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.